MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 256 filers reported holding MIRATI THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.67 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $8,371,000 | -54.6% | 124,700 | -44.4% | 0.03% | -48.1% |
| Q1 2022 | $18,440,000 | -37.9% | 224,277 | +29.5% | 0.05% | -29.9% |
| Q1 2021 | $29,672,000 | -18.0% | 173,216 | +5.2% | 0.08% | -26.0% |
| Q4 2020 | $36,165,000 | +2654.4% | 164,656 | +1981.6% | 0.10% | +1980.0% |
| Q3 2020 | $1,313,000 | +57.6% | 7,910 | +8.4% | 0.01% | +25.0% |
| Q2 2020 | $833,000 | -67.3% | 7,300 | -63.0% | 0.00% | -50.0% |
| Q4 2019 | $2,545,000 | -35.3% | 19,750 | -60.9% | 0.01% | -38.5% |
| Q3 2019 | $3,933,000 | -18.7% | 50,481 | +7.5% | 0.01% | -18.8% |
| Q2 2019 | $4,836,000 | +716.9% | 46,951 | +291.3% | 0.02% | +700.0% |
| Q2 2018 | $592,000 | -7.1% | 12,000 | -89.7% | 0.00% | -33.3% |
| Q2 2016 | $637,000 | +181.9% | 116,581 | +933.6% | 0.00% | +200.0% |
| Q2 2014 | $226,000 | – | 11,279 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aviva Holdings Ltd. | 3,135,966 | $136,602,679 | 87.83% |
| EcoR1 Capital, LLC | 5,748,399 | $250,400,260 | 8.45% |
| Boxer Capital, LLC | 3,201,440 | $139,454,726 | 7.42% |
| RTW INVESTMENTS, LP | 6,768,514 | $294,836,470 | 6.22% |
| Paradigm Biocapital Advisors LP | 1,668,116 | $72,663,133 | 4.93% |
| Avoro Capital Advisors LLC | 6,666,666 | $290,399,971 | 4.53% |
| Octagon Capital Advisors LP | 655,051 | $28,534,022 | 4.38% |
| Artal Group S.A. | 2,024,226 | $88,175 | 3.78% |
| Ally Bridge Group (NY) LLC | 70,283 | $3,061,527 | 3.59% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 216,000 | $9,404,640 | 3.17% |